Prestige Consumer Healthcare

PBH

Market cap $3.12B

TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market.

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Prestige Consumer Healthcare benefits from e-commerce momentum, acquisitions and solid solvency, even as inflation and tariff costs pose near-term risks.

Prestige Consumer Healthcare (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

The consensus price target hints at a 26.1% upside potential for Prestige Consumer Healthcare (PBH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?

Premium Brands Holdings Corporation ( PBH:CA ) Q3 2025 Earnings Call November 10, 2025 1:30 PM EST Company Participants George Paleologou - President, CEO & Director Will Kalutycz - Chief Financial Officer Conference Call Participants Christopher Li - Desjardins Securities Inc., Research Division Martin Landry - Stifel Nicolaus Canada Inc., Research Division Kyle McPhee - Cormark Securities Inc., Research Division Derek Lessard - TD Cowen, Research Division Luke Hannan - Canaccord Genuity Corp., Research Division Michael Glen - Raymond James Ltd., Research Division Stephen MacLeod - BMO Capital Markets Equity Research Ty Collin - CIBC Capital Markets, Research Division Vishal Shreedhar - National Bank Financial, Inc., Research Division John Zamparo - Scotiabank Global Banking and Markets, Research Division Ryland Conrad - RBC Capital Markets, Research Division Presentation George Paleologou President, CEO & Director Good morning, and welcome, everyone, to our 2025 Third Quarter Conference Call.

Prestige Consumer Healthcare Inc. ( PBH ) Q2 2026 Earnings Call November 6, 2025 8:30 AM EST Company Participants Philip Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President & CEO Christine Sacco - CFO & COO Conference Call Participants Susan Anderson - Canaccord Genuity Corp., Research Division Rupesh Parikh - Oppenheimer & Co. Inc., Research Division Keith Devas - Jefferies LLC, Research Division Jon Andersen - William Blair & Company L.L.C., Research Division Mitchell Pinheiro - Sturdivant & Co., Inc., Research Division Anthony Lebiedzinski - Sidoti & Company, LLC Douglas Lane - Water Tower Research LLC Presentation Operator Good day, and thank you for standing by.